The Role of BVA in Cardiorenal Syndrome Treatment and Outcomes
Live Webinar
March 20, 2024
5:00 PM EST
0
days
0
hours
0
minutes
0
seconds
About the Webinar
Join us for a discussion moderated by H. David Humes, MD, and panel members John L. Jefferies, MD, MBA, MPH, FACC, FAHA, FAAP, FHFSA, FRCPE, FESC Shree Mulay, MD, and, Avais Masud, MD, who will share how blood volume analysis (BVA) in cardiorenal syndrome (CRS) serves as a diagnostic tool that enhances the precision of diuretic and red cell therapies, significantly elevating the effectiveness of conventional care.
Our Moderator
H. David Humes, MD
Professor of Internal Medicine,
University of Michigan, Ann Arbor MI
Our Panel Members
John L. Jefferies,
MD, MBA, MPH, FACC, FAHA, FAAP, FHFSA, FRCPE, FESC
Professor, School of Public Health, University of Tennessee,
Memphis TN
Shree Mulay,
MD
The Kidney Experts,
Jackson, TN
Avais Masud,
MD
Nephrology Program Director of the Nephrology-Critical Care Fellowship program at Jersey Shore University Medical Center, Neptune NJ
What you
will learn
Comprehensive understanding of how BVA informs the evaluation and treatment of CRS
The diagnostic advantages of BVA compared to commonly used surrogate measures
BVA impact on clinical outcomes